IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 229 filers reported holding IVERIC BIO INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $33,137,484 | -17.2% | 1,362,001 | -27.1% | 0.22% | -32.6% |
| Q4 2022 | $40,007,325 | +19.3% | 1,868,628 | 0.0% | 0.32% | +49.1% |
| Q3 2022 | $33,523,000 | +86.5% | 1,868,628 | 0.0% | 0.21% | +101.9% |
| Q2 2022 | $17,976,000 | -42.8% | 1,868,628 | 0.0% | 0.11% | -25.4% |
| Q1 2022 | $31,449,000 | +1.1% | 1,868,628 | +0.5% | 0.14% | +21.4% |
| Q4 2021 | $31,096,000 | +23.9% | 1,859,817 | +20.3% | 0.12% | +13.6% |
| Q3 2021 | $25,098,000 | – | 1,545,425 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |